. 2024 Oct;35(19-20):814-824.

doi: 10.1089/hum.2024.035. Epub 2024 Jul 3.

AAV5 Delivery of CRISPR/Cas9 Mediates Genome Editing in the Lungs of Young Rhesus Monkeys

Shun-Qing Liang¹, Andrew W Navia^{2

3

4}, Michelle Ramseier^{2

3

4}, Xuntao Zhou¹, Michele Martinez⁵, Charles Lee⁵, Chen Zhou^{6

7}, Joae Wu⁸, Jun Xie^{6

7

9}, Qin Su^{6

7

9}, Dan Wang^{6

7}, Terence R Flotte⁶, Daniel G Anderson^{10

11

12

13}, Alice F Tarantal⁵, Alex K Shalek^{2

3

4}, Guangping Gao^{6

7

9}, Wen Xue^{1

7}

Affiliations

¹ RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
² Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
³ Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
⁴ Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
⁵ Departments of Pediatrics and Cell Biology and Human Anatomy, School of Medicine, and California National Primate Research Center, University of California, Davis, California, USA.
⁶ Horae Gene Therapy Center and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁷ Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁸ Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁹ Viral Vector Core, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
¹⁰ Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
¹¹ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
¹² Harvard and MIT Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
¹³ Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

PMID: 38767512
PMCID: PMC11511778 (available on 2025-10-14)
DOI: 10.1089/hum.2024.035

AAV5 Delivery of CRISPR/Cas9 Mediates Genome Editing in the Lungs of Young Rhesus Monkeys

Shun-Qing Liang et al. Hum Gene Ther. 2024 Oct.

. 2024 Oct;35(19-20):814-824.

doi: 10.1089/hum.2024.035. Epub 2024 Jul 3.

Authors

Affiliations

¹ RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
² Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
³ Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
⁴ Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
⁵ Departments of Pediatrics and Cell Biology and Human Anatomy, School of Medicine, and California National Primate Research Center, University of California, Davis, California, USA.
⁶ Horae Gene Therapy Center and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁷ Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁸ Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁹ Viral Vector Core, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
¹⁰ Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
¹¹ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
¹² Harvard and MIT Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
¹³ Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

PMID: 38767512
PMCID: PMC11511778 (available on 2025-10-14)
DOI: 10.1089/hum.2024.035

Abstract

Genome editing has the potential to treat genetic diseases in a variety of tissues, including the lung. We have previously developed and validated a dual adeno-associated virus (AAV) CRISPR platform that supports effective editing in the airways of mice. To validate this delivery vehicle in a large animal model, we have shown that intratracheal instillation of CRISPR/Cas9 in AAV5 can edit a housekeeping gene or a disease-related gene in the lungs of young rhesus monkeys. We observed up to 8% editing of angiotensin-converting enzyme 2 (ACE2) in lung lobes after single-dose administration. Single-nuclear RNA sequencing revealed that AAV5 transduces multiple cell types in the caudal lung lobes, including alveolar cells, macrophages, fibroblasts, endothelial cells, and B cells. These results demonstrate that AAV5 is efficient in the delivery of CRISPR/Cas9 in the lung lobes of young rhesus monkeys.

Keywords: AAV5; CRISPR; lung; rhesus monkey.

PubMed Disclaimer

Cited by

Structural framework to address variant-gene relationship in primary open-angle glaucoma.
Singh N, Kizhatil K, Duraikannu D, Choquet H, Saidas Nair K. Singh N, et al. Vision Res. 2025 Jan;226:108505. doi: 10.1016/j.visres.2024.108505. Epub 2024 Nov 8. Vision Res. 2025. PMID: 39520803 Review.

References

1. Schwank G, Koo BK, Sasselli V, et al. . Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 2013;13(6):653–658. - PubMed
1. Liu P, Liang SQ, Zheng C, et al. . Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Nat Commun 2021;12(1):2121. - PMC - PubMed
1. Doudna JA. The promise and challenge of therapeutic genome editing. Nature 2020;578(7794):229–236. - PMC - PubMed
1. Tarantal AF, Noctor SC, Hartigan-O’Connor DJ. Nonhuman primates in translational research. Annu Rev Anim Biosci 2022;10:441–468. - PMC - PubMed
1. Wang D, Zhang F, Gao G. CRISPR-based therapeutic genome editing: Strategies and in vivo delivery by AAV vectors. Cell 2020;181(1):136–150. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

AAV5 Delivery of CRISPR/Cas9 Mediates Genome Editing in the Lungs of Young Rhesus Monkeys

Affiliations

AAV5 Delivery of CRISPR/Cas9 Mediates Genome Editing in the Lungs of Young Rhesus Monkeys

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources